MADISON, Wis.--(BUSINESS WIRE)--In a recently published study in the journal Genome Research, a team of scientists led by Dr. Shaying Zhao at the University of Georgia have developed a novel cross-species comparative genomics and oncology strategy for cancer driver gene discovery, using microarray technologies from Roche NimbleGen (SWX:RO) (SWX:ROG) (Pink Sheets: RHHBY), that differs fundamentally from current approaches which focus on human cancers only. This study used NimbleGen CGH arrays to pinpoint genes likely responsible for colorectal cancer (CRC) by identifying genomic copy number abnormalities (CNAs) that are common in both canine and human CRC research samples (Genome Research, 2010, 20:341). The results of this study could have significant implications on research to develop future diagnostic assays and treatments for this devastating disease.
